#United States #Magnolia #RF Technology #Stratus Medical #neurovasis

Stratus Medical Secures $10 Million Funding for Pain Treatment Innovations

Stratus Medical, headquartered in Magnolia, Texas, is making headlines with its recent announcement of a $10 million Series B financing round, which aims to propel the company's development of advanced radiofrequency (RF) technologies targeted at alleviating chronic pain. The funding was primarily led by Wasatch Health Partners, a notable investment firm that specializes in growth equity and lower middle-market buyouts in the healthcare sector.

This latest investment is particularly crucial as it will enable Stratus Medical to finalize the development of its cutting-edge RF Generator and the neurovasis™ basivertebral nerve ablation (BVNA) technology. Moreover, the funds will be utilized to expand and strengthen the company's valuable patent portfolio and to finance a comprehensive clinical study that could validate their innovative solutions.

Chronic pain, particularly vertebrogenic low back pain, is a significant healthcare issue in the U.S., affecting over five million individuals. The pain often arises when the vertebral endplates in the spine are damaged, leading to substantial discomfort and impaired quality of life for patients. Currently, treatment options include a mix of medications, physical therapy, and techniques like basivertebral nerve ablation. Stratus Medical’s technologies seek not only to enhance these treatments but also to provide greater accessibility and efficacy for patients.

Luke Larsen, Vice President of Wasatch Health Partners, expressed enthusiasm regarding the partnership, commending Stratus Medical for its impressive execution and consistent revenue growth. He highlighted the healthcare company’s strong progress in technology development and clinical initiatives, remarking that the management team is well-positioned for ongoing success in the healthcare landscape.

Similarly, Bret Boudousquie, CEO of Stratus Medical, articulated gratitude for Wasatch Health Partners' long-standing belief in their mission. Commenting on the collaboration, Boudousquie said, “We are excited to further our work with leading physicians and institutions to provide groundbreaking RF technologies capable of benefiting chronic pain patients. Our aim is to deliver enhancements that will not only advance treatment options but also improve patients' quality of life.”

An integral part of Stratus Medical's innovation is the Nimbus® RF Multitined Expandable Electrode, which has already made significant inroads in the market due to its ease of use and effectiveness in achieving sustainable pain relief. The neurovasis technology builds upon this foundation, promising to enhance treatment efficacy and reduce costs for hospitals and ambulatory surgical centers.

Dr. Doug Beall, Director of Interventional Radiology at Clinical Radiology of Oklahoma, has been utilizing the Nimbus device since 2020 and has recently begun contributing to the neurovasis project. His efforts led to the publication of a scientific article in 2024 that details the neurovasis BVNA technique, emphasizing its potential to improve procedural efficiency drastically.

Stratus Medical is proud to announce that these innovative solutions have not yet been evaluated or cleared by the FDA, and continued research and clinical trials will be crucial in validating their effectiveness. The outlook remains bright for Stratus Medical as they continue to push boundaries in the medical device landscape while addressing a pressing need for chronic pain management options.

In conclusion, with the recent $10 million Series B financing, Stratus Medical is set to advance its mission of transforming pain management through innovation, ultimately benefiting the millions who endure chronic pain across the nation. This funding signifies not just a financial boost, but also a reaffirmation of belief in Stratus Medical’s vision to reshape the landscape of pain relief solutions.